Medicare Part D—the prescription drug coverage piece of Medicare—doesn't stay the same year to year. The program adjusts coverage rules, costs, and which drugs are covered based on government reviews and negotiations. Understanding what changed matters because your out-of-pocket costs and medication coverage could shift, even if you stay in the same plan.
Learn About Paying Your FGUA Bill Online →
One significant change that started in 2024 involves Medicare's new authority to negotiate drug prices directly with pharmaceutical companies. This represents the first time Medicare has had this power for certain high-cost medications. Starting with 10 drugs in 2024 (including medications for heart failure, arthritis, and diabetes), Medicare identified drugs where beneficiaries spend the most, then negotiated lower prices. The list expands to more medications in coming years. This negotiation affects what people actually pay out of pocket—when Medicare pays less for a drug, that savings often gets passed to the person taking it.
The coverage gap (sometimes called the "donut hole") continues to shrink. In 2024, once you and your plan spend $5,850 combined on covered drugs, you enter the gap where you previously paid full price. Now, even in the gap, brand-name drugs cost no more than 25% of the price, and generic drugs are typically 25% as well. This is different from years past when the gap meant paying much more. By 2025, the gap continues narrowing further, meaning fewer out-of-pocket costs when you hit that spending threshold.
Another change that affects many retirees: the Part D late enrollment penalty structure. If you didn't take Part D when you first became Medicare-eligible, the penalty you pay is recalculated annually. This means the amount you owe increases based on how long you went without coverage. Understanding this matters if you're considering enrolling late or switching plans.
Practical takeaway: Download your current plan's formulary (the list of covered drugs) and compare it to what's available now. Drug coverage can change, and a medication you take might move to a different tier, costing you more or less depending on the change. Checking this takes 15 minutes but could identify savings you're missing.
The drug price negotiation that Congress authorized represents a major shift in how Medicare operates. For decades, Medicare was not allowed to negotiate prices—it had to pay whatever drug companies charged. Starting in 2024, this changed. Medicare's Centers for Medicare and Medicaid Services (CMS) used claims data to identify which drugs cost beneficiaries the most money out of their own pockets, then negotiated with manufacturers to lower prices.
Free Guide to Pay by Plate Illinois Billing →
In the first round of negotiation, the following 10 drugs were selected: Atorvastatin (high cholesterol), Amlodipine (high blood pressure), Lisinopril (high blood pressure and heart failure), Albuterol inhaler (asthma and COPD), Metformin (type 2 diabetes), Sertraline (depression and anxiety), Fluoxetine (depression), Pravastatin (high cholesterol), Rosuvastatin (high cholesterol), and Januvia (type 2 diabetes). If you take any of these, pay attention to your Part D plan's pricing—CMS negotiated maximum prices went into effect January 1, 2025.
Here's how the savings work: When CMS negotiates a lower price with a drug manufacturer, the plan pays less to the pharmacy. That savings translates into lower copayments, coinsurance, or deductible amounts you pay. The amount of your personal savings depends on which tier your drug is on in your specific plan and how much of the medication you use in a year. Someone taking a negotiated drug might see their copay drop from $35 to $15, for example, or they might see their annual out-of-pocket costs decrease by hundreds of dollars if they take the medication regularly.
The negotiation list grows over time. In 2026, CMS can negotiate prices on up to 15 drugs. By 2029, up to 60 drugs can be included. The criteria for which drugs get selected focuses on high-cost medications with no competition from generics—basically, drugs where patients have limited options to save money elsewhere. This is why expensive biologic drugs and newer medications often end up on the negotiation list.
Practical takeaway: If you take one of the negotiated drugs, contact your Part D plan or pharmacy to ask about your current out-of-pocket cost versus what you paid last year. Savings might be automatic, but some people don't realize they're paying less. Also, mark your calendar to check which new drugs get added to the negotiation list each year (usually announced in August for the following year).
Part D costs have layers, and understanding where you sit in those layers determines how much you actually pay. Even though the structure stays consistent from year to year, the dollar amounts change annually, and importantly, how the coverage gap works has changed significantly in recent years.
Free Guide to Mold Removal Methods for Walls →
In 2025, the basic structure works like this: First, you have a deductible (the amount you pay before insurance kicks in). For most plans, this ranges from $0 to around $550, depending on which plan you choose. Some plans have no deductible at all. After you meet your deductible, you enter the initial coverage phase. In this phase, you typically pay a copayment or coinsurance for each prescription. The amounts vary by drug tier—generic drugs cost less than brand-name drugs, which cost less than specialty drugs. For example, a generic might be $5, a preferred brand-name $35, and a non-preferred brand-name $75.
Once your plan's total drug costs (not just what you pay, but what the plan pays plus what you pay) reach $5,850, you enter the coverage gap. This is the area that improved significantly. In the gap, your share of drug costs is capped at 25% for most medications. That means if a drug costs $100, you pay $25, and a manufacturer discount or plan covers the rest. This applies to both brand-name and generic drugs. You stay in the gap until your out-of-pocket costs reach $8,550. Then catastrophic coverage kicks in, where you pay only 5% of the cost for the rest of the year.
The numbers themselves change each year as drug prices and program costs shift. The initial coverage phase threshold of $5,850 and catastrophic threshold of $8,550 are set annually by CMS based on expected drug spending. This is why reviewing your options each year matters—your plan's specific copayments might change, affecting your total predicted costs.
One often-overlooked detail: manufacturer discounts applied during the initial coverage phase count toward your out-of-pocket maximum, but not all types of assistance count the same way. If you use a coupon or patient assistance program from a drug manufacturer, how it affects your thresholds depends on the specific program and plan.
Practical takeaway: Use Medicare's online Plan Finder tool (available at Medicare.gov) to enter the specific drugs you take and compare the total estimated costs for plans you're considering. This tool calculates where you'll be in each phase based on your actual medications and dosages. This is more accurate than just looking at copayment amounts, since total costs depend on how many prescriptions you fill and at what strength.
Part D plans are not static. Every year, plans adjust their formularies (the list of drugs they cover), change copayment amounts, modify which drugs require prior authorization, and sometimes add or remove step therapy requirements. A medication you've been taking for years might move from a $15 copay to a $45 copay, or might no longer be covered at all. This happens frequently enough that comparing plans annually is not optional—it's necessary to avoid paying thousands of dollars more than you need to.
How to Delete Your Fitbit Account Guide →
Insurance companies must notify members of formulary changes, but these notices often arrive in complicated documents that are easy to miss or misunderstand. The more reliable approach is to review your plan's current formulary document yourself before open enrollment ends. CMS allows you to switch Part D plans during the Annual Enrollment Period (October 15 through December 7 each year) and also allows changes if your current plan significantly modifies coverage for a drug you're taking
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.